Cetuximab observational study as first-line therapy in patients with metastatic colorectal cancer.

e15022Background: Cetuximab (Cmab) + chemotherapy is now indicated in various treatment guidelines as a first-line therapy for non-resectable metastatic colorectal cancer (mCRC). The efficacy of Cm...